advertisement
Chesnokova NB 6
Showing records 1 to 6 | Display only abstracts from Chesnokova NB in IGR 23-3109371 The rational design of novel 5-amino-2-oxindole derivatives with antiglaucomic activity
Eremeev RO; Beznos OV; Efremov AM; Chesnokova NB; Lozinskaya NA
Bioorganic and Medicinal Chemistry Letters 2023; 90: 129334 (IGR: 24-1/2)
108230 Microwave-Assisted Synthesis of 3-Hydroxy-2-oxindoles and Pilot Evaluation of Their Antiglaucomic Activity
Efremov AM; Beznos OV; Eremeev RO; Chesnokova NB; Milaeva ER; Shevtsova EF; Lozinskaya NA
International journal of molecular sciences 2023; 24: (IGR: 23-4)
106865 Gamma-Synuclein Dysfunction Causes Autoantibody Formation in Glaucoma Patients and Dysregulation of Intraocular Pressure in Mice
Pavlenko TA; Roman AY; Lytkina OA; Pukaeva NE; Everett MW; Sukhanova IS; Soldatov VO; Davidova NG; Chesnokova NB; Ovchinnikov RK; Kukharsky MS
Biomedicines 2022; 11: (IGR: 23-3)
85221 The role of the endothelin system in the pathogenesis of eye diseases
Chesnokova NB; Pavlenko TA; Beznos OV; Grigoryev AV
Vestnik Oftalmologii 2020; 136: 117-123 (IGR: 21-1)
71617 Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma
Chesnokova NB; Beznos OV; Lozinskaya NA; Volkova MS; Zaryanova EV; Zefirov NA; Grigoryev AV
Biomeditsinskaia khimiia 2017; 63: 75-80 (IGR: 18-3)
54829 Level of tear endothelin-1 and plasminogen in patients with glaucoma and proliferative diabetic retinopathy
Pavlenko TA; Chesnokova NB; Davydova HG; Okhotsimskaia TD; Beznos OV; Grigor'ev AV
Vestnik Oftalmologii 2013; 129: 20-23 (IGR: 15-3)
